Design
Review
Authors
Loading...
Personalized antiplatelet strategies remain investigational; leaves open validation of novel P2Y12 and thrombin inhibitors in prospective trials.
Key points are not available for this paper at this time.
Tantry et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: